Article -> Article Details
| Title | Europe In Vitro Diagnostics Market Size, Share, Trends, and Growth Report to 2026 |
|---|---|
| Category | Sciences --> Medical |
| Meta Keywords | Europe In Vitro Diagnostics Market, Europe In Vitro Diagnostics Market Report |
| Owner | Joey Moore |
| Description | |
| Market Overview The Europe in vitro diagnostics market was valued at USD 28.69 Billion in 2025 and is expected to reach USD 44.12 Billion by 2034, exhibiting a CAGR of 4.90% during the forecast period 2026-2034. The market growth is driven by enhanced healthcare infrastructure, rising chronic diseases requiring early diagnosis, adoption of AI and machine learning, and the shift to personalized medicine supported by the proliferation of private testing laboratories. Study Assumption Years
Europe In Vitro Diagnostics Market Key Takeaways
Sample Request Link: https://www.imarcgroup.com/Europe-In-Vitro-Diagnostics-Market/requestsample Market Growth Factors Technical advances and chronic and infectious diseases, becoming more popular, propel growth of the Europe in vitro diagnostics market. Heart disease, cancer, diabetes, and respiratory diseases, as chronic noncommunicable diseases, are the leading causes of early death. According to a 2025 WHO report, at least one in six Europeans die before the age of 70 on account of chronic diseases. Alongside continuous population growth and demographic change, these trends are driving demands for more regular diagnostic testing of populations and for cost-efficient, precise, and quick testing solutions for an aging population and emerging infectious agents. Such new technologies drive the market, as shown by the promising performance of the newly commercialized sample preparation systems and molecular diagnostics platforms MGI Tech's PrepALL as well as the AI-powered Smart8 system, announced at SLAS Europe 2025, Hamburg, Germany. Artificial intelligence, machine learning, and automation technologies in diagnostic systems may make workflow more efficient, limit errors, and allow thorough disease profiling. Multiplex tests and next-generation sequencing further empower precision patient management and diagnose accurately for improved outcomes. Government initiatives and healthcare infrastructure also support demand. For instance in December 2025 the European Health and Digital Executive Agency (HaDEA) announced new EU4Health projects to further extend exchange of laboratory results across the EU and to develop digital healthcare infrastructure, which expands access to diagnostics systems across EU countries. The programs would incentivize the development and uptake of advanced diagnostic technology that would improve cancer, infectious disease and genetic screening, with appropriate reimbursement and regulatory practices, regionally. Market Segmentation Test Type
Product
Instruments
Application
End User
Country
Regional Insights Germany dominates the Europe in vitro diagnostics market, commanding an 18% market share in 2025. This leadership is attributed to its advanced healthcare infrastructure, high adoption of diagnostic technologies, extensive healthcare expenditure, and a robust research ecosystem fostering continuous innovation. Government support for digital health and personalized medicine initiatives further fortify Germany’s position as the key growth driver in the European IVD landscape. Recent Developments & News In December 2025, BD (Becton, Dickinson and Company) expanded its BD MAX™ System menu by launching new IVDR-certified VIASURE assays, developed in collaboration with Certest Biotec. This enhancement broadens respiratory and sexually transmitted infection testing capabilities across European healthcare providers and strengthens compliance with the stringent EU In Vitro Diagnostic Regulation, elevating diagnostic accuracy and regulatory adherence. Key Players
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization. About Us IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. | |